An agent-based modelling framework to study growth mechanisms in EGFR-L858R mutant alveolar type II cells

Helena Coggan, Clare E. Weeden, Philip Pearce +4

Mutations in the epidermal growth factor receptor (EGFR) are common in non-small cell lung cancer (NSCLC), particularly in never-smoker patients. However, these mutations are not a…